Insulet
PODD
#1880
Rank
NZ$19.94 B
Marketcap
NZ$288.02
Share price
2.94%
Change (1 day)
-41.94%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): NZ$0.80 Billion

According to Insulet's latest financial reports the company's current earnings are NZ$2.90 Billion. In 2025 the company made an earning of NZ$0.69 Billion, an increase over its 2024 earnings that were of NZ$0.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.80 B15.56%
2025 NZ$0.69 B16.3%
2024 NZ$0.60 B36.76%
2023 NZ$0.43 B481.9%
2022 NZ$75.47 M-45.24%
2021 NZ$0.13 B43.35%
2020 NZ$96.13 M18.51%
2019 NZ$81.12 M41.16%
2018 NZ$57.46 M-711.95%
2017 -NZ$9.4 Million-56.85%
2016 -NZ$21.77 Million-79.31%
2015 -NZ$0.11 Billion63.85%
2014 -NZ$64.22 Million31.04%
2013 -NZ$49.01 Million-21.96%
2012 -NZ$62.8 Million
2010 -NZ$59.9 Million-42.38%
2009 -NZ$0.11 Billion-33.56%
2008 -NZ$0.16 Billion65.93%
2007 -NZ$94.29 Million209.75%
2006 -NZ$30.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.49 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.24 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$10.98 B 1,237.60%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
NZ$54.50 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-NZ$0.36 Billion-142.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
NZ$0.17 B-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$2.13 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA